Thomaidis, Thomas; Maderer, Annett; Schad, Arno et al.
AFATINIB COMBINED WITH GEMCITABINE/CISPLATIN IN CHEMOTHERAPY NAIVE PATIENTS WITH ADVANCED BILIARY TRACT CANCER: RESULTS AND TRANSLATIONAL ANALYSIS OF AN OPEN-LABEL, PHASE I TRIALGASTROENTEROLOGY. Bd. 156. H. 6. 2019 S. S1047-S1047
Christensen, Stefan; Buggisch, Peter; Mauss, Stefan et al.
Alcohol and Cannabis Consumption Does Not Diminish Cure Rates in a Real-World Cohort of Chronic Hepatitis C Virus Infected Patients on Opioid Substitution Therapy-Data From the German Hepatitis C-Registry (DHC-R)SUBSTANCE ABUSE-RESEARCH AND TREATMENT. Bd. 13. 2019
Tang, Yilang; Reissig, Sonja; Glasmacher, Elke et al.
Alternative Splice Forms of CYLD Mediate Ubiquitination of SMAD7 to Prevent TGFB Signaling and Promote ColitisGASTROENTEROLOGY. Bd. 156. H. 3. 2019 S. 692-+
Huang, J.; Doherty, M.; Regnier, S. et al.
AN INNOVATIVE TOOL BASED ON MACHINE LEARNING TECHNIQUES PREDICTS NASH PATIENTS IN REAL-WORLD SETTINGSHEPATOLOGY. Bd. 70. 2019 S. 124A-124A
Pearce, Simon H. S.; Dayan, Colin; Wraith, David C. et al.
Antigen-Specific Immunotherapy with Thyrotropin Receptor Peptides in Graves' Hyperthyroidism: A Phase I StudyTHYROID. Bd. 29. H. 7. 2019 S. 1003-1011
Castven, Darko; Becker, Diana; Czauderna, Carotin et al.
Application of patient-derived liver cancer cells for phenotypic characterization and therapeutic target identificationINTERNATIONAL JOURNAL OF CANCER. Bd. 144. H. 11. 2019 S. 2782-2794
Krieger, Christine C.; Boutin, Alisa; Jang, Daesong et al.
Arrestin-beta-1 Physically Scaffolds TSH and IGF1 Receptors to Enable CrosstalkENDOCRINOLOGY. Bd. 160. H. 6. 2019 S. 1468-1479
Neumann, Helmut; Bisschops, Raf
Artificial intelligence and the future of endoscopyDIGESTIVE ENDOSCOPY. Bd. 31. H. 4. 2019 S. 389-390
Schattenberg, Joern M.; Ekstedt, Mattias
Assessing the disease burden of non-alcoholic fatty liver disease in the real world - big data and big numbersBMC MEDICINE. Bd. 17. 2019
Younossi, Zobair M.; Stepanova, Maria; Nader, Fatema et al.
ASSESSMENT OF PATIENT-REPORTED OUTCOMES (PROs) IN PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS (NASH) TREATED WITH OBETICHOLIC ACID (OCA): RESULTS FROM REGENERATE PHASE 3 CLINICAL TRIALHEPATOLOGY. Bd. 70. 2019 S. 1366A-1368A